JuanJose Lahuerta Palacios

37PUBLICATIONS
187CO-AUTHORS
Medical mycologyPredictive and prognostic markersHaematological tumoursInnate immunityGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (37)

|Jul 24, 2026
MRD dynamics predicts progression and reveals a vulnerable state for immunotherapy interception in multiple myeloma.

|Jul 17, 2026
Study of post-translational modifications of p53 in multiple myeloma.

|Mar 11, 2026
Genetic Evidence against Clonotypic B Lymphocytes as a Reservoir for Plasma-cell Cancers.

Carmen González, Juan-Jose Garces, Hector Gracia

|Jan 29, 2026
Immune biomarkers of increased infection risk in multiple myeloma.

Aintzane Zabaleta, Luis-Esteban Tamariz-Amador, Ioannis V Kostopoulos

|Dec 11, 2025
Real-world evidence of measurable residual disease assessment in multiple myeloma.

Maria-Teresa Cedena, Noemi Puig, Bruno Paiva

|Jun 11, 2025
High-dose busulfan-melphalan vs melphalan and reinforced VRD for newly diagnosed multiple myeloma: a phase 3 GEM trial.

Juan José Lahuerta, Jesús San-Miguel, Ana Jiménez-Ubieto

Pageof 7

Frequent Collaborators

30 joint publications

María-Victoria Mateos

29 joint publications

Jesús San-Miguel Izquierdo

25 joint publications

Joaquín Martínez-López

24 joint publications

Bruno Paiva